La Vonda R. De Witt
As in-house counsel for Glaxo Wellcome (now GlaxoSmithKline) and Merck & Company, La Vonda counseled clients on global strategies for protecting new discoveries for oncology, cardiovascular and anti-inflammatory therapeutic agents (Glaxo) and antibiotic therapeutic agents (Merck). As outside counsel, La Vonda also has a proven track-record of successfully counseling key stakeholders on the procurement, management and defense of chemical and life sciences-related patents.
La Vonda also specializes in advising clients on copyright and trademark procurement, portfolio management and defense before the Trademark Trial and Appeal Board (TTAB), and state and federal courts; commercial agreements (including data and privacy), technology, and ethics and compliance.
Previously, La Vonda was an Examiner at the United States Patent and Trademark Office (USPTO) examining patent applications in the chemical and pharmaceutical arts. She was selected for USPTO details as an Assistant Solicitor in the USPTO’s Solicitor’s Office and as an Assistant Attorney in its Office of Legislative Affairs.